Paper4126572
Cost of preventing retrolental fibroplasia?
Cross KW. Lancet, 1973. Cited by 128 papers, by iCite.
Cite this record
ConductScience Library. Cost of preventing retrolental fibroplasia? Papers, record 4126572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4126572
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypoxia | Major topic |
| Incubators, Infant | Major topic |
| Retinopathy of Prematurity | Major topic |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Infant Mortality | |
| Infant, Newborn | |
| Male | |
| Oxygen | |
| Oxygen Consumption | |
| Partial Pressure | |
| United Kingdom | |
| United States |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42194471 | Retinopathy of Prematurity: Historical Evolution of Clinical Management and Medico-Legal Evaluation in Japan. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42194471 | PubMed |
| 41945472 | Oxygen diffusion kinetics, buffering capacity and phenotype: A narrative review of oxygen physiology and later phenotype in very preterm infants. | Exp Physiol | 2026 | https://conductscience.org/library/papers/41945472 | PubMed |
| 38751747 | Oxygen in the neonatal ICU: a complicated history and where are we now? | Front Pediatr | 2024 | https://conductscience.org/library/papers/38751747 | PubMed |
| 38032241 | Automated oxygen delivery for preterm infants with respiratory dysfunction. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/38032241 | PubMed |
| 37730731 | Variations in medical practice of retinopathy of prematurity among 8 Asian countries from an international survey. | Sci Rep | 2023 | https://conductscience.org/library/papers/37730731 | PubMed |
| 36276256 | Pathophysiology of retinopathy of prematurity. | Saudi J Ophthalmol | 2022 | https://conductscience.org/library/papers/36276256 | PubMed |
| 34942982 | Supplemental Oxygen in the Newborn: Historical Perspective and Current Trends. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34942982 | PubMed |
| 31664193 | Retinopathy of prematurity treatment: Asian perspectives. | Eye (Lond) | 2020 | https://conductscience.org/library/papers/31664193 | PubMed |
| 30995663 | Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity. | Med Princ Pract | 2019 | https://conductscience.org/library/papers/30995663 | PubMed |
| 29137074 | Refractive state and optical compositions of preterm children with and without retinopathy of prematurity in the first 6 years of life. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/29137074 | PubMed |
| 28539799 | Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. | Eye Brain | 2016 | https://conductscience.org/library/papers/28539799 | PubMed |
| 28398697 | Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28398697 | PubMed |
| 28191454 | How Should Oxygen Supplementation Be Guided by Pulse Oximetry in Children: Do We Know the Level? | Front Pediatr | 2016 | https://conductscience.org/library/papers/28191454 | PubMed |
| 27720550 | IGF-I in the clinics: Use in retinopathy of prematurity. | Growth Horm IGF Res | 2016 | https://conductscience.org/library/papers/27720550 | PubMed |
| 26795413 | The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial. | Eye (Lond) | 2016 | https://conductscience.org/library/papers/26795413 | PubMed |
| 26282827 | Algorithms that eliminate the effects of calibration artefact and trial-imposed offsets of Masimo oximeter in BOOST-NZ trial. | J Clin Monit Comput | 2016 | https://conductscience.org/library/papers/26282827 | PubMed |
| 24813808 | A randomised controlled trial of an automated oxygen delivery algorithm for preterm neonates receiving supplemental oxygen without mechanical ventilation. | Acta Paediatr | 2014 | https://conductscience.org/library/papers/24813808 | PubMed |
| 24366462 | Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. | Pediatr Res | 2013 | https://conductscience.org/library/papers/24366462 | PubMed |
| 21235822 | NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. | BMC Pediatr | 2011 | https://conductscience.org/library/papers/21235822 | PubMed |
| 20498174 | High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. | Pediatrics | 2010 | https://conductscience.org/library/papers/20498174 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4126572
GET https://conductscience.org/api/papers/v1/4126572/cited_by?page=2